Related Experiment Video
Updated: Jun 10, 2026

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
Published on: November 1, 2024
Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop
1Department of Biochemistry and Molecular Biology, Indiana University School of Medicine-Simon Cancer Center, Indianapolis, Indiana, USA.
Abstract:
Several nucleolar proteins, such as ARF, ribosomal protein (RP) L5, L11, L23 and S7, have been shown to induce p53 activation by inhibiting MDM2 E3 ligase activity and consequently to trigger cell cycle arrest and/or apoptosis. Our recent study revealed another nucleolar protein called nucleostemin (NS), a nucleolar GTP binding protein, as a novel regulator of the p53-MDM2 feedback loop. However, unlike other known nucleolar regulators of this loop, NS surprisingly plays a dual role, as both up and downregulations of its levels could turn on p53 activity. Here, we try to offer some prospective views for this unusual phenomenon by reconciling previously and recently published studies in the field in hoping to better depict the role of NS in linking the p53 pathway with ribosomal biogenesis during cell growth and proliferation as well as to propose NS as another potential molecular target for anti-cancer drug development.
Insights
Nucleostemin (NS), a nucleolar protein, uniquely regulates the p53-MDM2 pathway. Both increased and decreased NS levels activate p53, suggesting a dual role in cancer progression and potential therapeutic targeting.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Nucleolar proteins like ARF and ribosomal proteins regulate p53 activation by inhibiting MDM2.
- The p53-MDM2 feedback loop is crucial for cell cycle control and apoptosis.
- Nucleostemin (NS) is a nucleolar GTP-binding protein implicated in cell growth.
Purpose of the Study:
- To investigate the role of nucleostemin (NS) as a novel regulator of the p53-MDM2 feedback loop.
- To reconcile conflicting findings regarding NS's effect on p53 activity.
- To explore NS's function in linking the p53 pathway with ribosomal biogenesis and its potential as an anti-cancer target.
Main Methods:
- Literature review and analysis of existing studies on nucleolar proteins and the p53-MDM2 pathway.
- Reconciliation of previously published data with recent findings on nucleostemin.
- In silico or experimental validation (details not provided in abstract).
Main Results:
- Nucleostemin (NS) acts as a novel regulator of the p53-MDM2 feedback loop.
- Unlike other nucleolar regulators, NS exhibits a dual role: both upregulation and downregulation of NS activate p53.
- This dual role suggests a complex mechanism linking NS to p53 activity.
Conclusions:
- Nucleostemin's dual role in regulating p53 presents an unusual phenomenon in the context of nucleolar protein function.
- Understanding NS's role is key to elucidating its connection between the p53 pathway and ribosomal biogenesis.
- Nucleostemin emerges as a potential molecular target for developing novel anti-cancer therapies.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
The Nucleolus
The Nucleolus
Restarting Stalled Replication Forks
Destabilization of Microtubules

